Sarepta Therapeutics, Inc. lobbies on its own behalf. For Q3 2026 it reported $160K across 1 client report and lists 3 lobbyists across its filings. Issues include Budget/Appropriations, Health Issues, Science/Technology and Trade (domestic/foreign).
| Client | Reported | Issues |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | $160K | Budget/Appropriations, Health Issues, Science/Technology |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $650K | 1 |
| 2025 | $1.24M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.